Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Molycorp Posts $26.6 Mln Profit In Q4

Molycorp Inc (MCP: Quote) reported fourth quarter of 2011 net income attributable to common stockholders was $26.6 million, or $0.26 per share. Adjusted EPS of $0.41 per share takes into account certain non-cash and other out-of-ordinary operational and business expansion items as compared to U.S. GAAP earnings per share.

Quarterly net revenues were $132.9 million, significantly higher than $21.7 million in the fourth quarter of 2010.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $134.95 million for the quarter. Analysts' estimates typically exclude special items.

The Company re-affirmed its annual production of REO equivalent products to be in a range of 8,000 metric tons to 10,000 metric tons for the full year 2012.

Click here to receive FREE breaking news email alerts for Molycorp, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.